Novel Anti-Infective Technologies, LLC Report issue

For profit Phase 2
Founded: Houston TX United States (2012)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2015
NCT02577718
First Marketed Drug
2012
trimethoprim
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

NOVEL LABS INC